Fadaleh Sarah Abu, Shkrobot Jody, Makhinova Tatiana, Eurich Dean, Sadowski Cheryl A
Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Canada.
School of Public Health, University of Alberta, Canada.
Data Brief. 2020 Jun 8;31:105842. doi: 10.1016/j.dib.2020.105842. eCollection 2020 Aug.
The dataset covers the equations and procedure used for the estimation of an older adult's total annual medication costs, across Canadian provinces and territories; detailed to report pharmacy margin, government share, and patient share. We presented a case of an older adult using 10 different medications commonly used, according to Canadian Institute for Health Information. Eight different deprescribing scenarios were created, based on recommendations from Beers Criteria and the Canadian Deprescribing Network, for the purpose of comparing the cost difference before and after each intervention on pharmacies, patients, and governments. Scenarios included: (1) Stopping an over the counter medication; (2) Discontinuation of a medication; (3) Slow taper of a potentially inappropriate medication; (4) Rapid taper of a potentially inappropriate medication; (5) Switching to safer medication; (6) Dose reduction; (7) Switching to a lower cost medication; (8) Changing from combination to a single medication. The data presented are related to the article entitled "Financial advantage or barrier when deprescribing for seniors: A case based analysis" [1].
该数据集涵盖了用于估算加拿大各省和地区老年人年度药物总费用的方程式和程序；详细报告了药房利润、政府份额和患者份额。根据加拿大卫生信息研究所的数据，我们展示了一个使用10种常用药物的老年人案例。基于《Beers标准》和加拿大减药网络的建议，创建了8种不同的减药方案，目的是比较每次干预前后药房、患者和政府的成本差异。方案包括：(1)停用非处方药；(2)停药；(3)逐渐减少潜在不适当药物的用量；(4)快速减少潜在不适当药物的用量；(5)换用更安全的药物；(6)降低剂量；(7)换用成本更低的药物；(8)从复方药物改为单一药物。所呈现的数据与题为《老年人减药时的经济优势或障碍：基于案例的分析》[1]的文章相关。
